Technical Analysis for AVTE - Aerovate Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | 0.00% | |
Bullish Engulfing | Bullish | -0.37% | |
180 Bullish Setup | Bullish Swing Setup | -0.37% | |
Outside Day | Range Expansion | -0.37% | |
Wide Bands | Range Expansion | -0.37% | |
Doji - Bullish? | Reversal | 5.14% | |
Wide Bands | Range Expansion | 5.14% | |
NR7 | Range Contraction | 5.14% | |
Narrow Range Bar | Range Contraction | 5.14% | |
Wide Bands | Range Expansion | 5.14% |
Alert | Time |
---|---|
10 DMA Support | about 20 hours ago |
60 Minute Opening Range Breakout | about 21 hours ago |
Up 1% | about 22 hours ago |
Bullish 180 Entry | about 22 hours ago |
Rose Above Previous Day's High | about 22 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/12/2024
Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's initial focus is on advancing AV-101, its dry powder inhaled formulation of the drug imatinib for the treatment of pulmonary arterial hypertension, or PAH.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Chemical Compounds Hypertension Orphan Drug Pulmonary Arterial Hypertension Pulmonary Hypertension Imatinib Piperazines
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Chemical Compounds Hypertension Orphan Drug Pulmonary Arterial Hypertension Pulmonary Hypertension Imatinib Piperazines
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 32.415 |
52 Week Low | 1.25 |
Average Volume | 943,305 |
200-Day Moving Average | 11.20 |
50-Day Moving Average | 2.25 |
20-Day Moving Average | 2.53 |
10-Day Moving Average | 2.63 |
Average True Range | 0.13 |
RSI (14) | 60.78 |
ADX | 36.11 |
+DI | 30.78 |
-DI | 12.54 |
Chandelier Exit (Long, 3 ATRs) | 2.60 |
Chandelier Exit (Short, 3 ATRs) | 2.47 |
Upper Bollinger Bands | 2.98 |
Lower Bollinger Band | 2.08 |
Percent B (%b) | 0.64 |
BandWidth | 35.53 |
MACD Line | 0.11 |
MACD Signal Line | 0.12 |
MACD Histogram | -0.0147 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.79 | ||||
Resistance 3 (R3) | 2.79 | 2.75 | 2.77 | ||
Resistance 2 (R2) | 2.75 | 2.72 | 2.75 | 2.76 | |
Resistance 1 (R1) | 2.71 | 2.70 | 2.69 | 2.70 | 2.75 |
Pivot Point | 2.67 | 2.67 | 2.66 | 2.67 | 2.67 |
Support 1 (S1) | 2.62 | 2.64 | 2.60 | 2.62 | 2.57 |
Support 2 (S2) | 2.58 | 2.62 | 2.58 | 2.56 | |
Support 3 (S3) | 2.54 | 2.58 | 2.55 | ||
Support 4 (S4) | 2.53 |